Stay updated on NKTR-262 Combo + Nivolumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the NKTR-262 Combo + Nivolumab in Solid Tumors Clinical Trial page.

Latest updates to the NKTR-262 Combo + Nivolumab in Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedPage revision updated from v3.6.3 to v3.6.4, indicating a newer version of the study details page.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page revision stamp was updated to v3.6.3, replacing the previous v3.6.2. This indicates a general update to the page without altering the study data.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page footer now shows Revision: v3.6.2, replacing v3.6.0, indicating a site update. The study content remains unchanged.SummaryDifference0.0%

- Check54 days agoChange DetectedThe study page now indicates that recruitment has ended and adds new help/navigation sections for readers. The Intervention/Treatment header formatting is updated and the revision version is bumped to v3.6.0.SummaryDifference0.4%

- Check61 days agoChange DetectedRevision v3.5.5 replaces v3.5.4 on the page, signaling an updated page template or back-end content update.SummaryDifference0.0%

- Check82 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, indicating a backend or template update. No study content or data were modified as part of this change.SummaryDifference0.0%

Stay in the know with updates to NKTR-262 Combo + Nivolumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NKTR-262 Combo + Nivolumab in Solid Tumors Clinical Trial page.